Crescent Biopharma Inc
F:C68
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Crescent Biopharma Inc
F:C68
|
US |
|
Banco Santander SA
F:BSD2
|
ES |
|
Continental AG
F:CONA
|
DE |
|
D
|
DXC Technology Co
F:2XT
|
US |
|
X
|
Xcel Energy Inc
XMUN:NRN
|
US |
|
H
|
Hawaiian Electric Industries Inc
F:HWI
|
US |
|
T
|
Teva Pharmaceutical Industries Ltd
SWB:TEV
|
IL |
|
H
|
Hermes International SCA
XMUN:HMI
|
FR |
|
F
|
Fujikura Ltd
DUS:FJK
|
JP |
|
B
|
Barrick Gold Corp
XMUN:ABR
|
CA |
|
F
|
Franklin Electric Co Inc
F:FE4
|
US |
|
E
|
Electronic Arts Inc
XMUN:ERT
|
US |
|
M
|
Marsh & McLennan Companies Inc
XMUN:MSN
|
US |
Shareholder Yield
Current shareholder yield for C68 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
C68 Price
Crescent Biopharma Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -47% |
| Market Capitalization | 191.7m EUR |
| Shares Outstanding | 13 890 000 |
| Percentage of Shares Shorted |
N/A
|
